Virtu Financial’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Virtu Financial's ABCL Position: Q3 2026 in Review
Virtu Financial opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 20,890 shares worth $305K. The stake represents 0.01% of the portfolio and ranks #771 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ABCL as recently as Q4 2025.
Virtu Financial first reported a position in ABCL in Q3 2022 and has held it in 8 quarters since. The position peaked at $709K in Q2 2025. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Virtu Financial held 20,890 shares of AbCellera Biologics worth $305K as of Q3 2026.
- AbCellera Biologics was a new Virtu Financial position in Q3 2026.
- AbCellera Biologics made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #771 holding.
- Virtu Financial first reported a position in AbCellera Biologics in Q3 2022 and has held it in 8 quarters since.
- Virtu Financial's AbCellera Biologics position peaked at $709K in Q2 2025.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.